The board of directors of Consun Pharmaceutical Group Limited announced that Mr. AN Meng ("Mr. An") has been appointed as executive director and vice president of the Company and Mr. XU Hanxing ("Mr. Xu") has been appointed as executive director, general manager assistant and financial manager of the Company with effect from 24 March 2021, respectively. Mr. An has over 20 years of experience in the property insurance and venture capital industries. Mr. Xu joined the Company in November 2020 and is currently acting as a general manager assistant and financial manager. From September 2018 to November 2020, Mr. Xu worked with PricewaterhouseCoopers, Hong Kong and served as a senior associate.